http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#Head http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20 http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#assertion http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20 http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#provenance http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20 http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#pubinfo http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#assertion http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_1 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606 http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/serum%20ketone%20body http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/increases http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/serum%20glucose http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#assertion http://www.w3.org/2000/01/rdf-schema#label a(SCHEM:"serum glucose") -> a(SCHEM:"serum ketone body") http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_4 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_2 http://purl.org/dc/elements/1.1/identifier Diabetic ketoacidosis, The Merck Manual http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_2 http://purl.org/dc/elements/1.1/title Diabetic ketoacidosis, The Merck Manual http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_2 http://purl.org/dc/elements/1.1/type Other http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_3 http://www.w3.org/ns/prov#value Diabetic Ketoacidosis Metabolic acidosis from the accumulation of ketones due to severely depressed insulin levels. Diabetic ketoacidosis (DKA) results from grossly deficient insulin availability, causing a transition from glucose to lipid oxidation and metabolism (see below). In type I DM patients, DKA is commonly precipitated by a lapse in insulin treatment or by an acute infection, trauma, or infarction that makes usual insulin treatment inadequate. Although type II DM patients rarely have DKA, many may have ketone formation and acidosis (usually mild) because of a decrease in food intake and a marked decrease in insulin secretion due to severe and chronic hyperglycemia (glucose toxicity). http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_2 http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_2 http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#_3 http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20#pubinfo http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20 http://purl.org/dc/terms/created 2014-07-03T14:31:27.209+02:00 http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20 http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RA7T_HODw3W5ZXgm_W0fNJl85sK17-5gRN8MbAX7t7V20 http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234